American Vanguard Corp. (NYSE:AVD) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Monday.

According to Zacks, “AMERICAN VANGUARD CORP. is a holding company, which through its subsidiaries, is engaged in the manufacturer and formulation of chemicals for crops, human and animal health protection. These chemicals which include insecticides, fungicides, molluscicides, growth regulatorsain, and soil fumigants, are marketed in liquid, powder, and granular forms. “

Other research analysts have also issued reports about the stock. Roth Capital set a $18.00 target price on shares of American Vanguard Corp. and gave the company a “buy” rating in a report on Saturday. Feltl & Co. restated a “strong-buy” rating on shares of American Vanguard Corp. in a report on Wednesday, March 8th. Finally, Piper Jaffray Companies upgraded shares of American Vanguard Corp. from an “underweight” rating to a “neutral” rating and upped their target price for the company from $12.00 to $17.00 in a report on Monday, November 28th. Three research analysts have rated the stock with a hold rating, two have given a buy rating and one has assigned a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $17.50.

Analyst Recommendations for American Vanguard Corp. (NYSE:AVD)

This article was originally published by and is the sole property of American Banking News. If you happen to be reading this article on another website, it was stolen and illegally republished in violation of U.S. and International copyright law. The original version of this story can be read at https://www.americanbankingnews.com/2017/03/20/american-vanguard-corp-avd-upgraded-at-zacks-investment-research.html

Shares of American Vanguard Corp. (NYSE:AVD) traded up 0.64% on Monday, hitting $15.75. 114,064 shares of the company were exchanged. American Vanguard Corp. has a 52-week low of $12.60 and a 52-week high of $20.00. The firm has a market cap of $462.86 million, a P/E ratio of 35.80 and a beta of 1.27. The company has a 50-day moving average price of $16.34 and a 200 day moving average price of $16.80.

American Vanguard Corp. (NYSE:AVD) last released its earnings results on Monday, March 6th. The company reported $0.13 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.12 by $0.01. The company had revenue of $87.50 million for the quarter, compared to analyst estimates of $89.10 million. American Vanguard Corp. had a net margin of 3.86% and a return on equity of 4.36%. The firm’s quarterly revenue was up 4.8% on a year-over-year basis. During the same period in the prior year, the firm earned $0.10 EPS. Analysts predict that American Vanguard Corp. will post $0.62 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 14th. Stockholders of record on Friday, March 31st will be issued a dividend of $0.015 per share. This is a positive change from American Vanguard Corp.’s previous quarterly dividend of $0.01. This represents a $0.06 annualized dividend and a dividend yield of 0.38%. The ex-dividend date of this dividend is Wednesday, March 29th. American Vanguard Corp.’s dividend payout ratio is presently 9.76%.

Your IP Address:

In other news, insider Johann Venter sold 4,000 shares of the stock in a transaction dated Tuesday, March 14th. The shares were sold at an average price of $15.50, for a total transaction of $62,000.00. Following the transaction, the insider now directly owns 19,326 shares in the company, valued at approximately $299,553. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Eric G. Wintemute sold 10,000 shares of the stock in a transaction dated Tuesday, February 7th. The stock was sold at an average price of $16.40, for a total transaction of $164,000.00. Following the transaction, the chief executive officer now owns 890,845 shares in the company, valued at $14,609,858. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 52,075 shares of company stock worth $847,705. Insiders own 4.30% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Catalyst Capital Advisors LLC bought a new position in shares of American Vanguard Corp. during the third quarter valued at $128,000. Wells Fargo & Company MN raised its position in shares of American Vanguard Corp. by 44.9% in the third quarter. Wells Fargo & Company MN now owns 10,915 shares of the company’s stock valued at $175,000 after buying an additional 3,381 shares during the last quarter. Hartford Investment Management Co. raised its position in shares of American Vanguard Corp. by 18.3% in the third quarter. Hartford Investment Management Co. now owns 12,300 shares of the company’s stock valued at $198,000 after buying an additional 1,900 shares during the last quarter. Susquehanna International Group LLP bought a new position in shares of American Vanguard Corp. during the third quarter valued at $292,000. Finally, Texas Permanent School Fund raised its position in shares of American Vanguard Corp. by 0.3% in the third quarter. Texas Permanent School Fund now owns 19,675 shares of the company’s stock valued at $316,000 after buying an additional 62 shares during the last quarter. Institutional investors and hedge funds own 78.59% of the company’s stock.

American Vanguard Corp. Company Profile

American Vanguard Corporation (AVD) operates as a holding company. The Company conducts its business through its subsidiaries, AMVAC Chemical Corporation (AMVAC), GemChem, Inc (GemChem), 2110 Davie Corporation (DAVIE), Quimica Amvac de Mexico SA de C.V. (AMVAC M), AMVAC Mexico Sociedad de Responsabilidad Limitada (AMVAC M Srl), AMVAC de Costa Rica Sociedad de Responsabilidad Limitada (AMVAC CR Srl), AMVAC Switzerland GmbH (AMVAC S), AMVAC do Brasil Representacoes Ltda (AMVAC B), AMVAC CV (AMVAC CV), AMVAC Netherlands BV (AMVAC BV) and Envance Technologies, LLC (Envance).

5 Day Chart for NYSE:AVD

Get a free copy of the Zacks research report on American Vanguard Corp. (AVD)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for American Vanguard Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard Corp. and related companies with MarketBeat.com's FREE daily email newsletter.